RAPT Therapeutics, Inc. Deferred Revenue (Non-Current)
RAPT Therapeutics, Inc. had Deferred Revenue (Non-Current) of $241.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2023-03-14
- 2022-03-31: Deferred Revenue, Noncurrent $241.00K.
- 2021-12-31: Deferred Revenue, Noncurrent $511.00K.
- 2021-09-30: Deferred Revenue, Noncurrent $745.00K.
- 2021-06-30: Deferred Revenue, Noncurrent $967.00K.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2022-03-31 | $241.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $511.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $745.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $967.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $983.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $863.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.13M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $1.77M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $3.30M 10-Q · filed 2020-05-14 |